UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study

Annals of the rheumatic diseases, 2018-09, Vol.77 (9), p.1295-1302

2018

Volltextzugriff (PDF)

Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study

Annals of the rheumatic diseases, 2023-11, Vol.82 (11), p.1387-1393

2023

Volltextzugriff (PDF)

IL33: Roles in Allergic Inflammation and Therapeutic Perspectives

Frontiers in immunology, 2019-03, Vol.10, p.364-364

2019

Volltextzugriff (PDF)

Efficacy and safety of biologics targeting interleukin-6, -12/23 and -17 pathways for peripheral psoriatic arthritis: a network meta-analysis

Rheumatology (Oxford, England), 2018-03, Vol.57 (3), p.563-571

2018

Volltextzugriff (PDF)

Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak

Annals of the rheumatic diseases, 2021-06, Vol.80 (6), p.e97-e97

2021

Volltextzugriff (PDF)

Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study

Seminars in arthritis and rheumatism, 2024-04, Vol.65, p.152416-152416, Article 152416

2024

Volltextzugriff (PDF)

Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations

Gut, 2020-04, Vol.69 (4), p.617-629

2020

Volltextzugriff (PDF)

Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria in Patients With Idiopathic Inflammatory Myopathy and Anti–Melanoma Differentiation–Associated Protein 5 Positivity

Arthritis & rheumatology (Hoboken, N.J.), 2022-09, Vol.74 (9), p.1588-1592

2022

Volltextzugriff (PDF)

The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study

Frontiers in medicine, 2021-12, Vol.8, p.743180-743180

2021

Volltextzugriff (PDF)

Deciphering global trends in immune‐mediated inflammatory diseases: A three‐decade epidemiological journey

Rheumatology & autoimmunity (Print), 2024-03, Vol.4 (1), p.67-67

2024

Volltextzugriff (PDF)

Role of inflammatory burden and treatment on joint space width in psoriatic arthritis-a high-resolution peripheral quantitative computed tomography study

Arthritis research & therapy, 2023-08, Vol.25 (1), p.138-138, Article 138

2023

Volltextzugriff (PDF)

Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis

Frontiers in medicine, 2018-01, Vol.4, p.262-262

2018

Volltextzugriff (PDF)

Repair of Bone Erosion in Rheumatoid Arthritis by Denosumab: A High‐Resolution Peripheral Quantitative Computed Tomography Study

Arthritis care & research (2010), 2017-08, Vol.69 (8), p.1156-1163

2017

Volltextzugriff (PDF)

Urinary Long Non-Coding RNA Levels as Biomarkers of Lupus Nephritis

International journal of molecular sciences, 2023-07, Vol.24 (14), p.11813

2023

Volltextzugriff (PDF)

Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’

Annals of the rheumatic diseases, 2023-08, Vol.82 (8), p.e187-e187

2023

Volltextzugriff (PDF)

Immunogenicity and safety of inactivated and mRNA COVID-19 vaccines in patients with systemic lupus erythematosus

Therapeutic advances in musculoskeletal disease, 2022-04, Vol.14, p.1759720X221089586-1759720X221089586

2022

Volltextzugriff (PDF)

Effect of Achieving Minimal Disease Activity on the Progression of Subclinical Atherosclerosis and Arterial Stiffness: A Prospective Cohort Study in Psoriatic Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2019-02, Vol.71 (2), p.271-280

2019

Volltextzugriff (PDF)

DCES-PA: Deformation-controllable elastic shape model for 3D bone proliferation analysis using hand HR-pQCT images

Computers in biology and medicine, 2024-06, Vol.175, p.108533-108533, Article 108533

2024

Volltextzugriff (PDF)

The impact of comorbidities in patients with spondyloarthritis

International journal of rheumatic diseases, 2023-07, Vol.26 (7), p.1222-1224

2023

Volltextzugriff (PDF)

Gut Microbiome and Its Interaction with Immune System in Spondyloarthritis

Microorganisms (Basel), 2020-11, Vol.8 (11), p.1727

2020

Volltextzugriff (PDF)

DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study

Annals of the rheumatic diseases, 2020-10, Vol.79 (10), p.1320-1326

2020

Volltextzugriff (PDF)

Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID‐19 pandemic

International journal of rheumatic diseases, 2021-06, Vol.24 (6), p.733-745

2021

Volltextzugriff (PDF)

Care for patients with rheumatic diseases during COVID‐19 pandemic: A position statement from APLAR

International journal of rheumatic diseases, 2020-06, Vol.23 (6), p.717-722

2020

Volltextzugriff (PDF)

Use of telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak: The 6-month results of a randomized controlled trial

Lupus, 2022-04, Vol.31 (4), p.488-494

2022

Volltextzugriff (PDF)

1 – 25 von 260

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(238)
Mit Volltextzugriff
(188)

Publikationsform

Sprache

Englisch
(260)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(212)
Life Sciences & Biomedicine
(197)
Humans
(146)
Rheumatology
(132)
Female
(109)
Male
(92)
Middle Aged
(90)
Adult
(85)
Biological And Medical Sciences
(55)
Medical Sciences
(54)
Systemic Lupus Erythematosus
(43)
Severity Of Illness Index
(41)
Risk Factors
(38)
Diseases Of The Osteoarticular System
(35)
Rheumatoid Arthritis
(35)
Psoriatic Arthritis
(33)
Aged
(26)
Arthritis
(21)
Antirheumatic Agents - Therapeutic Use
(20)
Inflammation
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study

Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement

IL33: Roles in Allergic Inflammation and Therapeutic Perspectives

Efficacy and safety of biologics targeting interleukin-6, -12/23 and -17 pathways for peripheral psoriatic arthritis: a network meta-analysis

Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak

Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study

Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations

Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria in Patients With Idiopathic Inflammatory Myopathy and Anti–Melanoma Differentiation–Associated Protein 5 Positivity

The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study

Deciphering global trends in immune‐mediated inflammatory diseases: A three‐decade epidemiological journey

Role of inflammatory burden and treatment on joint space width in psoriatic arthritis-a high-resolution peripheral quantitative computed tomography study

Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis

Repair of Bone Erosion in Rheumatoid Arthritis by Denosumab: A High‐Resolution Peripheral Quantitative Computed Tomography Study

Urinary Long Non-Coding RNA Levels as Biomarkers of Lupus Nephritis

Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’

Immunogenicity and safety of inactivated and mRNA COVID-19 vaccines in patients with systemic lupus erythematosus

Effect of Achieving Minimal Disease Activity on the Progression of Subclinical Atherosclerosis and Arterial Stiffness: A Prospective Cohort Study in Psoriatic Arthritis

DCES-PA: Deformation-controllable elastic shape model for 3D bone proliferation analysis using hand HR-pQCT images

The impact of comorbidities in patients with spondyloarthritis

Gut Microbiome and Its Interaction with Immune System in Spondyloarthritis

DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study

Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID‐19 pandemic

Care for patients with rheumatic diseases during COVID‐19 pandemic: A position statement from APLAR

Use of telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak: The 6-month results of a randomized controlled trial

Suchergebnisse filtern